Post-IPO Debt - Zogenix
Investment Firm
Overview
Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.
Announced Date
Sep 22, 2020
Closed on Date
Oct 05, 2020
Funding Type
Post Ipo Debt
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
No investment info available on this profile
Round Details and Background
Zogenix raised $230000000 on 2020-09-22 in Post-IPO Debt
Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.
Company Funding History
16
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 28, 2006 |  Series A - Zogenix | 5 | - | 60.0M |
| Jan 09, 2008 | Series B - Zogenix | 4 | - | 18.0M |
| Dec 15, 2009 | Series B - Zogenix | 1 | - | 35.0M |
| Oct 05, 2009 | Series B - Zogenix | 5 | - | 36.0M |
Recent Activity
There is no recent news or activity for this profile.